Xenetic Biosciences XBIO
NASDAQ XBIO
$2.24 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Xenetic Biosciences (XBIO) Depreciation & Amortization - Total (2011 - 2013)

Updated

Xenetic Biosciences (XBIO) reported Depreciation & Amortization - Total of $5,313 for Q3 2013, unchanged from $5,313 a year earlier.

Analysis

Xenetic Biosciences (XBIO) Depreciation & Amortization - Total (2011 - 2013) Analysis & Trends

Over the twelve months ended May 31, 2013, Xenetic Biosciences' Depreciation & Amortization - Total came in at $21,252; for FY2012, it came in at $19,481.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Tot) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Xenetic Biosciences 5.25 Mn -20.58 Mn - -
Historic Data

Historic Data

Download Data
DateValue
May 31, 2013 5,313.00
Nov 30, 2012 5,313.00
Aug 31, 2012 5,313.00
May 31, 2012 5,313.00
Feb 29, 2012 5,313.00
Nov 30, 2011 3,542.00
API Access

Xenetic Biosciences Depreciation & Amortization - Total API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-total&ticker=XBIO&period=max&api_key=YOUR_API_KEY